Recurrent pituitary apoplexy: experience from a national registry and review of the literature
Therapeutic Advances in Endocrinology and Metabolism · 2026-03 · 17
DOI: 10.1177/20420188261434641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Endocrinology and Metabolism, online erschienen am 28.03.2026. Verfasst von Betina Biagetti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Nutrition Department, Hospital Universitario Vall de Hebrón, Universitat Autònoma de Barcelona, ENDO-ERN, Pg. de la Vall d'Hebron, …. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Pituitary apoplexy (PA) is a neuroendocrine emergency characterized by acute hemorrhage or infarction of a pituitary adenoma. While its initial presentation and management are well documented, data on recurrent PA remain scarce.
Objectives
To determine the prevalence, clinical characteristics, and predictors of recurrent PA in a national cohort, and to contextualize findings through a structured review of the literature.
Design
Multicenter retrospective cohort study complemented by a structured literature review.
Methods
We analyzed 274 patients from the Spanish Pituitary Apoplexy Registry (2010–2023) with complete follow-up. Recurrent PA was defined as a new acute episode with radiological evidence of hemorrhage or infarction within a previously affected lesion. Clinical, radiological, and treatment-related variables were compared between recurrent and non-recurrent cases. A complementary literature review identified published reports of recurrence.
Results
Recurrent PA occurred in 9 patients (3.3%), including 6 of 214 with nonfunctioning adenomas (2.8%) and 3 of 60 with functioning adenomas (5.0%). Compared with nonrecurrent cases, patients with recurrence had significantly larger tumors (median 35 vs 25 mm; p = 0.006), higher rates of cavernous sinus invasion (77.9% vs 37.3%; p = 0.006), and more frequent prior cabergoline therapy (33.3% vs 6.3%; p = 0.020). Median time to recurrence was 18 months (range, 2–108). The literature review identified 11 studies reporting recurrence rates of 2.6%–16.7%, with more consistent estimates (4%–9.6%) in larger series ( n ⩾ 50). All recurrent cases showed a favorable clinical course and recovery.
Conclusion
Recurrent PA is uncommon, affecting approximately 3% of patients with a prior apoplexy episode. Given the low frequency of recurrence, the associated factors identified should be interpreted cautiously and considered primarily hypothesis-generating. The second episode was not more severe than the initial event, and the long-term prognosis was favorable.
Trial registration
Not applicable.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endocrinology and Nutrition Department, Hospital Universitario Vall de Hebrón, Universitat Autònoma de Barcelona, ENDO-ERN, Pg. de la Vall d'Hebron, 119, Horta-Guinardó, Barcelona 08035, Spain.
- Neurosurgery Department, Hospital Universitario Vall de Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, Spain.
- Department of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
- Endocrinology and Nutrition Service, La Fe University Hospital, Valencia, Spain.
- Endocrinology and Nutrition Department, Hospital de la Santa Creu i Sant Pau, IR-SANTPAU, ENDO-ERN, Barcelona, Spain.
ORCID-Profile: Betina Biagetti, Marta Araujo-Castro
Zitieren
APA
Biagetti, B., Cordero Asanza, E., Iglesias, P., Camara, R., Asla, Q., Vicente, A., Martinez-Saez, E., Sarria-Estrada, S., Puig-Domingo, M., & Araujo-Castro, M. (2026). Recurrent pituitary apoplexy: experience from a national registry and review of the literature. Therapeutic Advances in Endocrinology and Metabolism, 17. https://doi.org/10.1177/20420188261434641
Vancouver
Biagetti B, Cordero Asanza E, Iglesias P, Camara R, Asla Q, Vicente A, et al. Recurrent pituitary apoplexy: experience from a national registry and review of the literature. Therapeutic Advances in Endocrinology and Metabolism. 2026;17. doi:10.1177/20420188261434641
BibTeX
@article{Biagetti2026,
author = {Biagetti, Betina and Cordero Asanza, Esteban and Iglesias, Pedro and Camara, Rosa and Asla, Queralt and Vicente, Almudena and Martinez-Saez, Elena and Sarria-Estrada, Silvana and Puig-Domingo, Manel and Araujo-Castro, Marta},
title = {Recurrent pituitary apoplexy: experience from a national registry and review of the literature},
journal = {Therapeutic Advances in Endocrinology and Metabolism},
year = {2026},
volume = {17},
doi = {10.1177/20420188261434641}
}
EUVIMED